. . . . . . . . . "However, other atypical antipsychotics, such as lurasidone, are often considered for off-label use in the treatment of irritability, whether because of tolerability issues with risperidone and aripiprazole or because of the drug-refractory nature of this symptom cluster." . . . . . . "Children and adolescents" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "F3u8v+B2DVgllbbcaNH8Cj/MupuR51Yo9wLvqzs2J9P6EjIORFqr4e1h97SeBQFXuO9JFDf3NQ8c3hJTFibDdkwLG5uDpFoQi3Og0MkStw+aNH0t7+kQNRghNkfMaRSdcMBy1OoYbjRZObncfJ/HUp0rkOCiaFt/didAXIsFqnQ=" . . "2021-05-25T14:35:02.341+02:00"^^ . . . . .